Hypertrophic Cardiomyopathy Webinars

Imaging for the Diagnosis and Management of Hypertrophic Cardiomyopathy
Presenters: Theodore Abraham, MD; Ethan Rowin, MD
Moderator: James E. Udelson, MD, FAHA

Hypertrophic cardiomyopathy is the most common form of genetic heart disease and can affect people of any age, yet it often goes undiagnosed. Diagnosis is typically done by echocardiogram to assess the thickness of the heart muscle and observe blood flow in and out of the heart.

Viewers will earn about the role of imaging in the diagnosis and treatment of patients with HCM.

 

Theodore Abraham, MD
Director, HCM Center of Excellence
UCSF

 

 

Ethan Rowin, MD
Co-Director, HCM Institute
Tufts Medical Center

 

 

James E. Udelson, MD, FAHA
Chief, Division of Cardiology
Tufts Medical Center

 

 

Hypertrophic Cardiomyopathy: An Introduction and Overview

Presenters: Dr. Sharon Cresci, Dr. Robert Fraser
Moderator: Dr. James Udelson

Summary: Hypertrophic cardiomyopathy or HCM is a primary myocardial disorder defined by left ventricular (LV) hypertrophy that cannot be explained by another cardiac or systemic disease. Some people with HCM experience symptoms such as fatigue, fainting, shortness of breath, chest pain or palpitations. Others with HCM do not experience any symptoms. Listen to experts as they explore the HCM symptoms, epidemiology, pathophysiology and the burden of the disease on patients and families.

Learn more about HCM in this free webinar so you are better able to discuss its impact with your patients.

Robert J. Fraser, MD 
Minneapolis Heart Institute®
Abbot Northwestern Hospital & Hennepin County Medical Center

 

 

Sharon Cresci, MD, FAHA, FACC, FASE
Washington University, Cardiovascular Division
Associate Professor of Medicine, Associate Professor of Genetics

 

 

James E. Udelson, MD, FAHA
Chief, Division of Cardiology
Tufts Medical Center

Clinical Implications of Genetic Testing in Hypertrophic Cardiomyopathy

Presenters: Dr. Anjali Owens, Dr. Sharon Cresci
Moderator: Dr. James Udelson

Summary: It is estimated that 1 in every 500 adults living in the U.S. have HCM, but a large percentage of patients are undiagnosed.  Which of your patients is undiagnosed? Hypertrophic Cardiomyopathy (HCM) is the most common form of genetic heart disease and can affect people of any age. HCM can be a debilitating and life-changing disease. People with HCM are often forced to make lifestyle changes, such as limiting their activity, to accommodate their disease. Sometimes this accommodation might not even be noticed by the patient themselves meaning careful questioning of symptoms and changes in activity are critical.

Learn more about HCM in this free webinar so you are better able to discuss its impact with your patients.

Anjali Tiku Owens, MD
Assistant Professor of Medicine
University of Pennsylvania

 

 

Sharon Cresci, MD, FAHA, FACC, FASE
Washington University, Cardiovascular Division
Associate Professor of Medicine, Associate Professor of Genetics

 

 

James E. Udelson, MD, FAHA
Chief, Division of Cardiology
Tufts Medical Center